These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


81 related items for PubMed ID: 11362479

  • 1. [Oral ganciclovir for the prevention of illnesses caused by CMV].
    Vianna G.
    Sidahora; 1995; ():33-4. PubMed ID: 11362479
    [Abstract] [Full Text] [Related]

  • 2. Oral ganciclovir.
    Schouten JT.
    STEP Perspect; 1995; 7(3):1, 11. PubMed ID: 11362979
    [Abstract] [Full Text] [Related]

  • 3. Treatment of cytomegalovirus esophagitis in patients with acquired immune deficiency syndrome: a randomized controlled study of foscarnet versus ganciclovir. The Italian Cytomegalovirus Study Group.
    Parente F, Bianchi Porro G.
    Am J Gastroenterol; 1998 Mar; 93(3):317-22. PubMed ID: 9517631
    [Abstract] [Full Text] [Related]

  • 4. Foscavir receives new indication.
    AIDS Alert; 1997 Jun; 12(6):71. PubMed ID: 11364364
    [Abstract] [Full Text] [Related]

  • 5. Ganciclovir implants: one year later.
    Cadman J.
    GMHC Treat Issues; 1997 Jun; 11(4/5):3-6. PubMed ID: 11364375
    [Abstract] [Full Text] [Related]

  • 6. Oral ganciclovir approved for CMV.
    Common Factor; 1995 Apr; (no 10):21. PubMed ID: 11362347
    [Abstract] [Full Text] [Related]

  • 7. Foscarnet treatment of cytomegalovirus gastrointestinal infections in acquired immunodeficiency syndrome patients who have failed ganciclovir induction.
    Dieterich DT, Poles MA, Dicker M, Tepper R, Lew E.
    Am J Gastroenterol; 1993 Apr; 88(4):542-8. PubMed ID: 8385880
    [Abstract] [Full Text] [Related]

  • 8. CMV treatment.
    Treat Rev; 1995 Apr; (no 19):4. PubMed ID: 11362756
    [Abstract] [Full Text] [Related]

  • 9. Oral ganciclovir effective for CMV.
    Grodeck B.
    Posit Aware; 1995 Apr; ():9. PubMed ID: 11362580
    [Abstract] [Full Text] [Related]

  • 10. CMV: the other virus.
    Smart T.
    GMHC Treat Issues; 1996 Mar; 10(3):10-1. PubMed ID: 11363389
    [Abstract] [Full Text] [Related]

  • 11. A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.
    Reddy AJ, Zaas AK, Hanson KE, Palmer SM.
    J Heart Lung Transplant; 2007 Dec; 26(12):1286-92. PubMed ID: 18096480
    [Abstract] [Full Text] [Related]

  • 12. [Cytomegalovirus polyradiculomyelopathy in AIDS].
    Jayaweera DT, Cassetti LI, Espinoza L, Lopardo GD, Hansman-Whiteman ML, Scerpella EG.
    Medicina (B Aires); 1998 Dec; 58(2):135-40. PubMed ID: 9706245
    [Abstract] [Full Text] [Related]

  • 13. [Cytomegaloviruses--clinical aspects and therapy].
    Hamprecht K, Jahn G.
    Ther Umsch; 1994 Aug; 51(8):551-7. PubMed ID: 7940412
    [Abstract] [Full Text] [Related]

  • 14. Oral ganciclovir approved.
    Gold D.
    GMHC Treat Issues; 1995 Jan; 9(1):10. PubMed ID: 11367376
    [Abstract] [Full Text] [Related]

  • 15. Treatment review.
    Treat Rev; 1995 Jan; (no 16):5. PubMed ID: 11362290
    [Abstract] [Full Text] [Related]

  • 16. Oral ganciclovir approved.
    AIDS Treat News; 1995 Jan 06; (No 214):1. PubMed ID: 11362183
    [Abstract] [Full Text] [Related]

  • 17. CMV news.
    Posit Aware; 1996 Jan 06; 7(1):5-6. PubMed ID: 11363124
    [Abstract] [Full Text] [Related]

  • 18. New developments in the delivery of ganciclovir for cytomegalovirus (CMV retinitis).
    Woodward J.
    STEP Perspect; 1995 Jan 06; 7(2):2-4. PubMed ID: 11362720
    [Abstract] [Full Text] [Related]

  • 19. Valganciclovir: new preparation. CMV retinitis: a simpler, oral treatment.
    Prescrire Int; 2003 Aug 06; 12(66):133-5. PubMed ID: 12906021
    [Abstract] [Full Text] [Related]

  • 20. Spectrum and treatment of cytomegalovirus disease in persons with AIDS.
    Spector SA.
    J Int Assoc Physicians AIDS Care; 1996 May 06; 2(5):9-12, 15-22. PubMed ID: 11363539
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.